Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Transparency

So just to be clear, if there were $80M on the balance sheet (approx. 19 cents per share) then in your estimation, the share price would still be in the 14 cents range because of the USPTO re-examination issues?

Share
New Message
Please login to post a reply